Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: An [18F]DOPA PET and fMRI study

Seoyoung Kim, Wi Hoon Jung, Oliver D. Howes, Mattia Veronese, Federico E. Turkheimer, Yun Sang Lee, Jae Sung Lee, Euitae Kim, Jun Soo Kwon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Given that only a subgroup of patients with schizophrenia responds to first-line antipsychotic drugs, a key clinical question is what underlies treatment response. Observations that prefrontal activity correlates with striatal dopaminergic function, have led to the hypothesis that disrupted frontostriatal functional connectivity (FC) could be associated with altered dopaminergic function. Thus, the aim of this study was to investigate the relationship between frontostriatal FC and striatal dopamine synthesis capacity in patients with schizophrenia who had responded to first-line antipsychotic drug compared with those who had failed but responded to clozapine. Methods: Twenty-four symptomatically stable patients with schizophrenia were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 under clozapine (clozapine group), along with 12 matched healthy controls. All participants underwent resting-state functional magnetic resonance imaging and [18F]DOPA PET scans. Results: No significant difference was found in the total PANSS score between the patient groups. Voxel-based analysis showed a significant correlation between frontal FC to the associative striatum and the influx rate constant of [18F]DOPA in the corresponding region in the first-line AP group. Region-of-interest analysis confirmed the result (control group: R2 = 0.019, p = 0.665; first-line AP group: R2 = 0.675, p < 0.001; clozapine group: R2 = 0.324, p = 0.054) and the correlation coefficients were significantly different between the groups. Conclusions: The relationship between striatal dopamine synthesis capacity and frontostriatal FC is different between responders to first-line treatment and clozapine treatment in schizophrenia, indicating that a different pathophysiology could underlie schizophrenia in patients who respond to first-line treatments relative to those who do not.

Original languageEnglish
Pages (from-to)2533-2542
Number of pages10
JournalPsychological medicine
Volume49
Issue number15
DOIs
StatePublished - 1 Nov 2019

Fingerprint

Corpus Striatum
Clozapine
Antipsychotic Agents
Dopamine
Schizophrenia
Magnetic Resonance Imaging
Therapeutics
Positron-Emission Tomography
Control Groups

Keywords

  • Dopamine
  • PET
  • functional connectivity
  • resting-state functional MRI
  • schizophrenia

Cite this

@article{ab0456be15b847d6a6f68f02bc2c6367,
title = "Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: An [18F]DOPA PET and fMRI study",
abstract = "Background: Given that only a subgroup of patients with schizophrenia responds to first-line antipsychotic drugs, a key clinical question is what underlies treatment response. Observations that prefrontal activity correlates with striatal dopaminergic function, have led to the hypothesis that disrupted frontostriatal functional connectivity (FC) could be associated with altered dopaminergic function. Thus, the aim of this study was to investigate the relationship between frontostriatal FC and striatal dopamine synthesis capacity in patients with schizophrenia who had responded to first-line antipsychotic drug compared with those who had failed but responded to clozapine. Methods: Twenty-four symptomatically stable patients with schizophrenia were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 under clozapine (clozapine group), along with 12 matched healthy controls. All participants underwent resting-state functional magnetic resonance imaging and [18F]DOPA PET scans. Results: No significant difference was found in the total PANSS score between the patient groups. Voxel-based analysis showed a significant correlation between frontal FC to the associative striatum and the influx rate constant of [18F]DOPA in the corresponding region in the first-line AP group. Region-of-interest analysis confirmed the result (control group: R2 = 0.019, p = 0.665; first-line AP group: R2 = 0.675, p < 0.001; clozapine group: R2 = 0.324, p = 0.054) and the correlation coefficients were significantly different between the groups. Conclusions: The relationship between striatal dopamine synthesis capacity and frontostriatal FC is different between responders to first-line treatment and clozapine treatment in schizophrenia, indicating that a different pathophysiology could underlie schizophrenia in patients who respond to first-line treatments relative to those who do not.",
keywords = "Dopamine, PET, functional connectivity, resting-state functional MRI, schizophrenia",
author = "Seoyoung Kim and Jung, {Wi Hoon} and Howes, {Oliver D.} and Mattia Veronese and Turkheimer, {Federico E.} and Lee, {Yun Sang} and Lee, {Jae Sung} and Euitae Kim and Kwon, {Jun Soo}",
year = "2019",
month = "11",
day = "1",
doi = "10.1017/S0033291718003471",
language = "English",
volume = "49",
pages = "2533--2542",
journal = "Psychological Medicine",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "15",

}

Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness : An [18F]DOPA PET and fMRI study. / Kim, Seoyoung; Jung, Wi Hoon; Howes, Oliver D.; Veronese, Mattia; Turkheimer, Federico E.; Lee, Yun Sang; Lee, Jae Sung; Kim, Euitae; Kwon, Jun Soo.

In: Psychological medicine, Vol. 49, No. 15, 01.11.2019, p. 2533-2542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness

T2 - An [18F]DOPA PET and fMRI study

AU - Kim, Seoyoung

AU - Jung, Wi Hoon

AU - Howes, Oliver D.

AU - Veronese, Mattia

AU - Turkheimer, Federico E.

AU - Lee, Yun Sang

AU - Lee, Jae Sung

AU - Kim, Euitae

AU - Kwon, Jun Soo

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Background: Given that only a subgroup of patients with schizophrenia responds to first-line antipsychotic drugs, a key clinical question is what underlies treatment response. Observations that prefrontal activity correlates with striatal dopaminergic function, have led to the hypothesis that disrupted frontostriatal functional connectivity (FC) could be associated with altered dopaminergic function. Thus, the aim of this study was to investigate the relationship between frontostriatal FC and striatal dopamine synthesis capacity in patients with schizophrenia who had responded to first-line antipsychotic drug compared with those who had failed but responded to clozapine. Methods: Twenty-four symptomatically stable patients with schizophrenia were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 under clozapine (clozapine group), along with 12 matched healthy controls. All participants underwent resting-state functional magnetic resonance imaging and [18F]DOPA PET scans. Results: No significant difference was found in the total PANSS score between the patient groups. Voxel-based analysis showed a significant correlation between frontal FC to the associative striatum and the influx rate constant of [18F]DOPA in the corresponding region in the first-line AP group. Region-of-interest analysis confirmed the result (control group: R2 = 0.019, p = 0.665; first-line AP group: R2 = 0.675, p < 0.001; clozapine group: R2 = 0.324, p = 0.054) and the correlation coefficients were significantly different between the groups. Conclusions: The relationship between striatal dopamine synthesis capacity and frontostriatal FC is different between responders to first-line treatment and clozapine treatment in schizophrenia, indicating that a different pathophysiology could underlie schizophrenia in patients who respond to first-line treatments relative to those who do not.

AB - Background: Given that only a subgroup of patients with schizophrenia responds to first-line antipsychotic drugs, a key clinical question is what underlies treatment response. Observations that prefrontal activity correlates with striatal dopaminergic function, have led to the hypothesis that disrupted frontostriatal functional connectivity (FC) could be associated with altered dopaminergic function. Thus, the aim of this study was to investigate the relationship between frontostriatal FC and striatal dopamine synthesis capacity in patients with schizophrenia who had responded to first-line antipsychotic drug compared with those who had failed but responded to clozapine. Methods: Twenty-four symptomatically stable patients with schizophrenia were recruited from Seoul National University Hospital, 12 of which responded to first-line antipsychotic drugs (first-line AP group) and 12 under clozapine (clozapine group), along with 12 matched healthy controls. All participants underwent resting-state functional magnetic resonance imaging and [18F]DOPA PET scans. Results: No significant difference was found in the total PANSS score between the patient groups. Voxel-based analysis showed a significant correlation between frontal FC to the associative striatum and the influx rate constant of [18F]DOPA in the corresponding region in the first-line AP group. Region-of-interest analysis confirmed the result (control group: R2 = 0.019, p = 0.665; first-line AP group: R2 = 0.675, p < 0.001; clozapine group: R2 = 0.324, p = 0.054) and the correlation coefficients were significantly different between the groups. Conclusions: The relationship between striatal dopamine synthesis capacity and frontostriatal FC is different between responders to first-line treatment and clozapine treatment in schizophrenia, indicating that a different pathophysiology could underlie schizophrenia in patients who respond to first-line treatments relative to those who do not.

KW - Dopamine

KW - PET

KW - functional connectivity

KW - resting-state functional MRI

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85057011025&partnerID=8YFLogxK

U2 - 10.1017/S0033291718003471

DO - 10.1017/S0033291718003471

M3 - Article

AN - SCOPUS:85057011025

VL - 49

SP - 2533

EP - 2542

JO - Psychological Medicine

JF - Psychological Medicine

SN - 0033-2917

IS - 15

ER -